Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate | Zendy

Radoje Čólović | Zendy; Marjan Micev | Zendy; Slavko Matić | Zendy; Nataša Čolović | Zendy; Nikica Grubor | Zendy; Henry Dushan Atkinson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate

Author(s) -

Radoje Čólović,

Marjan Micev,

Slavko Matić,

Nataša Čolović,

Nikica Grubor,

Henry Dushan Atkinson

Publication year - 2013

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp1302225c

Subject(s) - imatinib mesylate , medicine , stomach , curvatures of the stomach , gist , metastasis , stromal tumor , histopathology , pathology , radiology , gastroenterology , cancer , imatinib , stromal cell , myeloid leukemia

Gastrointestinal stromal tumors (GISTs) are rare and account for 0.1%-3% of all gastrointestinal neoplasms. GISTs are most commonly located in the stomach (60%) and 20%-25% are malignant, with metastases involving the peritoneum or the liver. Cystic liver metastases are extremely rare. Only two previous cases of patients with cystic liver metastases, prior to treatment with imatinib mesylate, have been described so far.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research